丁笠
Date of Birth:1986-09-04
Gender:Male
Education Level:With Certificate of Graduation for Doctorate Study
Alma Mater:中国药科大学
Paper Publications
-
Ding Li,王鹏宇,Xinyue Zhang.基于纳米金的肿瘤靶向给药系统的研究进展.中国现代应用药学,2021,38(13)1639-1646.
-
Ding Li,An Inter-Supplementary Biohybrid System Based on Natural Killer Cells for the Combinational Immunotherapy and Virotherapy of Cancer.[SCI].Advanced Science,2021,9(2):
-
Ding Li,张智萍,赵晨宏,陈磊,陈志强,张杰,刘雅娴,Xinyue Zhang.Ribosomal L1 domain-containing protein 1 coordinates with HDM2 to negatively regulate p53 in human colorectal Cancer cells.JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH,2021,40(1)
-
Ding Li,Xinyue Zhang.纳米金用于肿瘤免疫治疗的研究进展.中国肿瘤,2021,30(1)58-66.
-
Ding Li,Xinyue Zhang.靶向突变型p53的抗肿瘤药物研究进展.扬州大学学报:农业与生命科学版,2020,41(6)57-63.
-
Ding Li,王鹏宇,Xinyue Zhang.基于纳米金的肿瘤靶向给药系统的研究进展.中国现代应用药学,2021,38(13)1639-1646.
-
Ding Li,“走近现代生命科学”核心通识课程的线上教学启示.教育教学论坛,2020,49187-189.
-
Ding Li,Xinyue Zhang.靶向突变型p53的抗肿瘤药物研究进展.扬州大学学报(农业与生命科学版),2020,41(06)57-63.
-
Ding Li,孙若男,Xinyue Zhang.Rap2b siRNA significantly enhances the anticancer therapeutic efficacy of adriamycin in a gold nanoshell-based drug/gene co-delivery system.ONCOTARGET,2017,8(13)21200-21211.